ArticleScientific reports2024

Long-term hepatobiliary disorder associated with trastuzumab emtansine pharmacovigilance study using the FDA Adverse Event Reporting System database.

Hyo Jung Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.